Harmony Biosciences Receives U.S. Food and Drug Administration Approval for WAKIX® (pitolisant) for the Treatment of Cataplexy in Pediatric Narcolepsy
PLYMOUTH MEETING, Pa.–(BUSINESS WIRE)–Feb. 17, 2026– Harmony Biosciences (Nasdaq: HRMY) today announced that the U.S. Food and Drug....





